Not Enough New Pfizer Products, Butler Says

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

May 1 (Bloomberg) -- Tony Butler, an analyst at Barclays Capital, talks about Pfizer Inc.'s first-quarter profit and the outlook for the company's stock. The world's largest drugmaker reported that net income fell 19 percent in the quarter. Butler speaks with Scarlet Fun on Bloomberg Television's "InBusiness." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change